Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group
Gespeichert in:
| Veröffentlicht in: | JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 2020-08, Vol.33 (4), p.235-238 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 238 |
|---|---|
| container_issue | 4 |
| container_start_page | 235 |
| container_title | JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY |
| container_volume | 33 |
| creator | Mitchell, Jolyon P Berlinski, Ariel Canisius, Sebastian Cipolla, David Dolovich, Myrna B Gonda, Igor Hochhaus, Guenther Kadrichu, Nani Lyapustina, Svetlana Mansour, Heidi M Darquenne, Chantal Clark, Andy R Newhouse, Michael Ehrmann, Stephan Humphries, Robert Boushey, Homer |
| description | |
| doi_str_mv | 10.1089/jamp.2020.1622 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_proquest_miscellaneous_2418125612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2428157171</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-2962961bd4a5056652f76652661fae6a1ca4abfefb2a8b7ae3e888a371ebaaf33</originalsourceid><addsrcrecordid>eNpdks9v0zAUxwMCsTG4cOCInsRlO7TEzs_uFrXQVWqZtDKu0Uvy0rpL7GA7Q91fP6cdPSBFTmJ93vf7tfz1vM_MHzM_nXzbYduNuc_db8z5a--cTUI24okfvDl9M3bmvTdm5_sxC-PgnXcW8Cid-El8_urTvd6QtJB1HWEDtVYtLKQlLdEKJd3WWpWC7B5qpSEjrYxqDAgJK6pEKSTB5WKdra5g1mshNzC9_b2YjdjkGqaNkKJ0CjMqhXFisMIH0gZQVjBXj86jddYOyFwEZ2JgvVV9U8FUSSMq0mC35NJssaEK7lRvCVQNWdU6YWP1IeE1ZLC2aGnQOuY_TLlMcEebvkGr9P7g6TBZoa7E02ESFsb0zvQn2b9KPwzh51r13QfvbY2NoY8v7wvv_sf3X9Ob0fJ2vphmy1EZ8sSO-CR2DyuqECM_iuOI18mwxjGrkWJkJYZY1FQXHNMiQQooTVMMEkYFYh0EF97VUdedL--0aFHvc4Uiv8mW-bDnBxFL04A9MsdeHtlOqz8utM1bYUpqGpSkepPzkKWMRzHjDv36H7pTvbvOZqB4yqKEJYPg-EiV7kaNpvqUgPn50Kx8aFY-NCsfmuUGvrzI9kVL1Qn_V6XgGYeFzCg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2428157171</pqid></control><display><type>article</type><title>Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Mitchell, Jolyon P ; Berlinski, Ariel ; Canisius, Sebastian ; Cipolla, David ; Dolovich, Myrna B ; Gonda, Igor ; Hochhaus, Guenther ; Kadrichu, Nani ; Lyapustina, Svetlana ; Mansour, Heidi M ; Darquenne, Chantal ; Clark, Andy R ; Newhouse, Michael ; Ehrmann, Stephan ; Humphries, Robert ; Boushey, Homer</creator><creatorcontrib>Mitchell, Jolyon P ; Berlinski, Ariel ; Canisius, Sebastian ; Cipolla, David ; Dolovich, Myrna B ; Gonda, Igor ; Hochhaus, Guenther ; Kadrichu, Nani ; Lyapustina, Svetlana ; Mansour, Heidi M ; Darquenne, Chantal ; Clark, Andy R ; Newhouse, Michael ; Ehrmann, Stephan ; Humphries, Robert ; Boushey, Homer</creatorcontrib><identifier>ISSN: 1941-2711</identifier><identifier>EISSN: 1941-2703</identifier><identifier>DOI: 10.1089/jamp.2020.1622</identifier><identifier>PMID: 32589076</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Administration, Inhalation ; Aerosols ; Betacoronavirus ; Coronavirus Infections - drug therapy ; COVID-19 ; Decision Making ; Health technology assessment ; Human health and pathology ; Humans ; Life Sciences ; Pandemics ; Pneumonia, Viral - drug therapy ; Pulmonology and respiratory tract ; SARS-CoV-2 ; Societies, Medical ; Standardization</subject><ispartof>JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2020-08, Vol.33 (4), p.235-238</ispartof><rights>Copyright Mary Ann Liebert, Inc. Aug 2020</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-2962961bd4a5056652f76652661fae6a1ca4abfefb2a8b7ae3e888a371ebaaf33</citedby><cites>FETCH-LOGICAL-c427t-2962961bd4a5056652f76652661fae6a1ca4abfefb2a8b7ae3e888a371ebaaf33</cites><orcidid>0000-0001-6221-4467</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32589076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03518831$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Mitchell, Jolyon P</creatorcontrib><creatorcontrib>Berlinski, Ariel</creatorcontrib><creatorcontrib>Canisius, Sebastian</creatorcontrib><creatorcontrib>Cipolla, David</creatorcontrib><creatorcontrib>Dolovich, Myrna B</creatorcontrib><creatorcontrib>Gonda, Igor</creatorcontrib><creatorcontrib>Hochhaus, Guenther</creatorcontrib><creatorcontrib>Kadrichu, Nani</creatorcontrib><creatorcontrib>Lyapustina, Svetlana</creatorcontrib><creatorcontrib>Mansour, Heidi M</creatorcontrib><creatorcontrib>Darquenne, Chantal</creatorcontrib><creatorcontrib>Clark, Andy R</creatorcontrib><creatorcontrib>Newhouse, Michael</creatorcontrib><creatorcontrib>Ehrmann, Stephan</creatorcontrib><creatorcontrib>Humphries, Robert</creatorcontrib><creatorcontrib>Boushey, Homer</creatorcontrib><title>Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group</title><title>JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY</title><addtitle>J Aerosol Med Pulm Drug Deliv</addtitle><subject>Administration, Inhalation</subject><subject>Aerosols</subject><subject>Betacoronavirus</subject><subject>Coronavirus Infections - drug therapy</subject><subject>COVID-19</subject><subject>Decision Making</subject><subject>Health technology assessment</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - drug therapy</subject><subject>Pulmonology and respiratory tract</subject><subject>SARS-CoV-2</subject><subject>Societies, Medical</subject><subject>Standardization</subject><issn>1941-2711</issn><issn>1941-2703</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdks9v0zAUxwMCsTG4cOCInsRlO7TEzs_uFrXQVWqZtDKu0Uvy0rpL7GA7Q91fP6cdPSBFTmJ93vf7tfz1vM_MHzM_nXzbYduNuc_db8z5a--cTUI24okfvDl9M3bmvTdm5_sxC-PgnXcW8Cid-El8_urTvd6QtJB1HWEDtVYtLKQlLdEKJd3WWpWC7B5qpSEjrYxqDAgJK6pEKSTB5WKdra5g1mshNzC9_b2YjdjkGqaNkKJ0CjMqhXFisMIH0gZQVjBXj86jddYOyFwEZ2JgvVV9U8FUSSMq0mC35NJssaEK7lRvCVQNWdU6YWP1IeE1ZLC2aGnQOuY_TLlMcEebvkGr9P7g6TBZoa7E02ESFsb0zvQn2b9KPwzh51r13QfvbY2NoY8v7wvv_sf3X9Ob0fJ2vphmy1EZ8sSO-CR2DyuqECM_iuOI18mwxjGrkWJkJYZY1FQXHNMiQQooTVMMEkYFYh0EF97VUdedL--0aFHvc4Uiv8mW-bDnBxFL04A9MsdeHtlOqz8utM1bYUpqGpSkepPzkKWMRzHjDv36H7pTvbvOZqB4yqKEJYPg-EiV7kaNpvqUgPn50Kx8aFY-NCsfmuUGvrzI9kVL1Qn_V6XgGYeFzCg</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Mitchell, Jolyon P</creator><creator>Berlinski, Ariel</creator><creator>Canisius, Sebastian</creator><creator>Cipolla, David</creator><creator>Dolovich, Myrna B</creator><creator>Gonda, Igor</creator><creator>Hochhaus, Guenther</creator><creator>Kadrichu, Nani</creator><creator>Lyapustina, Svetlana</creator><creator>Mansour, Heidi M</creator><creator>Darquenne, Chantal</creator><creator>Clark, Andy R</creator><creator>Newhouse, Michael</creator><creator>Ehrmann, Stephan</creator><creator>Humphries, Robert</creator><creator>Boushey, Homer</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-6221-4467</orcidid></search><sort><creationdate>20200801</creationdate><title>Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group</title><author>Mitchell, Jolyon P ; Berlinski, Ariel ; Canisius, Sebastian ; Cipolla, David ; Dolovich, Myrna B ; Gonda, Igor ; Hochhaus, Guenther ; Kadrichu, Nani ; Lyapustina, Svetlana ; Mansour, Heidi M ; Darquenne, Chantal ; Clark, Andy R ; Newhouse, Michael ; Ehrmann, Stephan ; Humphries, Robert ; Boushey, Homer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-2962961bd4a5056652f76652661fae6a1ca4abfefb2a8b7ae3e888a371ebaaf33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Administration, Inhalation</topic><topic>Aerosols</topic><topic>Betacoronavirus</topic><topic>Coronavirus Infections - drug therapy</topic><topic>COVID-19</topic><topic>Decision Making</topic><topic>Health technology assessment</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - drug therapy</topic><topic>Pulmonology and respiratory tract</topic><topic>SARS-CoV-2</topic><topic>Societies, Medical</topic><topic>Standardization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mitchell, Jolyon P</creatorcontrib><creatorcontrib>Berlinski, Ariel</creatorcontrib><creatorcontrib>Canisius, Sebastian</creatorcontrib><creatorcontrib>Cipolla, David</creatorcontrib><creatorcontrib>Dolovich, Myrna B</creatorcontrib><creatorcontrib>Gonda, Igor</creatorcontrib><creatorcontrib>Hochhaus, Guenther</creatorcontrib><creatorcontrib>Kadrichu, Nani</creatorcontrib><creatorcontrib>Lyapustina, Svetlana</creatorcontrib><creatorcontrib>Mansour, Heidi M</creatorcontrib><creatorcontrib>Darquenne, Chantal</creatorcontrib><creatorcontrib>Clark, Andy R</creatorcontrib><creatorcontrib>Newhouse, Michael</creatorcontrib><creatorcontrib>Ehrmann, Stephan</creatorcontrib><creatorcontrib>Humphries, Robert</creatorcontrib><creatorcontrib>Boushey, Homer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mitchell, Jolyon P</au><au>Berlinski, Ariel</au><au>Canisius, Sebastian</au><au>Cipolla, David</au><au>Dolovich, Myrna B</au><au>Gonda, Igor</au><au>Hochhaus, Guenther</au><au>Kadrichu, Nani</au><au>Lyapustina, Svetlana</au><au>Mansour, Heidi M</au><au>Darquenne, Chantal</au><au>Clark, Andy R</au><au>Newhouse, Michael</au><au>Ehrmann, Stephan</au><au>Humphries, Robert</au><au>Boushey, Homer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group</atitle><jtitle>JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY</jtitle><addtitle>J Aerosol Med Pulm Drug Deliv</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>33</volume><issue>4</issue><spage>235</spage><epage>238</epage><pages>235-238</pages><issn>1941-2711</issn><eissn>1941-2703</eissn><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>32589076</pmid><doi>10.1089/jamp.2020.1622</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-6221-4467</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1941-2711 |
| ispartof | JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2020-08, Vol.33 (4), p.235-238 |
| issn | 1941-2711 1941-2703 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2418125612 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Administration, Inhalation Aerosols Betacoronavirus Coronavirus Infections - drug therapy COVID-19 Decision Making Health technology assessment Human health and pathology Humans Life Sciences Pandemics Pneumonia, Viral - drug therapy Pulmonology and respiratory tract SARS-CoV-2 Societies, Medical Standardization |
| title | Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A14%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urgent%20Appeal%20from%20International%20Society%20for%20Aerosols%20in%20Medicine%20(ISAM)%20During%20COVID-19:%20Clinical%20Decision%20Makers%20and%20Governmental%20Agencies%20Should%20Consider%20the%20Inhaled%20Route%20of%20Administration:%20A%20Statement%20from%20the%20ISAM%20Regulatory%20and%20Standardization%20Issues%20Networking%20Group&rft.jtitle=JOURNAL%20OF%20AEROSOL%20MEDICINE%20AND%20PULMONARY%20DRUG%20DELIVERY&rft.au=Mitchell,%20Jolyon%20P&rft.date=2020-08-01&rft.volume=33&rft.issue=4&rft.spage=235&rft.epage=238&rft.pages=235-238&rft.issn=1941-2711&rft.eissn=1941-2703&rft_id=info:doi/10.1089/jamp.2020.1622&rft_dat=%3Cproquest_hal_p%3E2428157171%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2428157171&rft_id=info:pmid/32589076&rfr_iscdi=true |